Key resources table.
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Strain, strain background (Staphylococcus aureus) | Wood46 | PMID:28360163 | ATCC 10832 | |
Strain, strain background(S. aureus) |
USA300 LAC; LAC WT (AH1263) | PMID:20418950 | AH1263 | |
Strain, strain background(S. aureus) |
USA300 LAC ∆spa, sbi::Tn; LAC∆spa∆sbi (AH4116) | This paper(Ibberson et al., 2014) | AH4116 | sbi::Tn in USA300 LAC ∆spa (AH3052) |
Strain, strain background(S. aureus) |
USA300 LAC AH4802 | PMID:31723175 | AH4802 | |
Antibody | (Goat polyclonal) anti-human IgG F(ab′)2- APC | Jackson ImmunoResearch | Cat # 109-136-088;RRID:AB_2337691 | (1:500) |
Antibody | (Goat polyclonal) anti-human-kappa F(ab′)2-A647 | Southern Biotech | Cat # 2062-31;RRID:AB_2795742 | (1:500) |
Antibody | (Humanized monoclonal)palivizumab | MedImmune | SYNAGIS | |
Cell line | EXPI293F cell | Life Technologies | RRID:CVCL_D615 | |
Recombinant DNA reagent |
pcDNA3.4(plasmid) | Thermo Fisher Scientific | Cat # A14697 | |
Recombinant DNA reagent |
pFUSE-CLIg- hk(plasmid) |
Invivogen | Cat # pfuse2-hclk | |
Recombinant DNA reagent |
pFUSE-CHIg-hG1(plasmid) | Invivogen | Cat # pfuse-hchg1 | |
Recombinant DNA reagent |
pFUSE-CHIg-hG3(plasmid) | Invivogen | Cat # pfuse-hchg301 | |
Chemical compound, drug |
Bifunctional CHXA″ | Macrocyclics | ||
Chemical compound, drug |
[111In]InCl3 | Curium Pharma | ||
Software, algorithm |
FlowJo version 10 |
BD Biosciences | RRID:SCR_008520 | |
Software, algorithm |
PMOD software |
PMOD Technologies | RRID:SCR_016547 | |
Other | Syto9 stain | Invitrogen | Live/Dead BacLight Bacterial Viability Kit |
(6 µM) |